Nel, ASAs

Nel ASA's €135M EU Grant and New Electrolyzer Platform Fail to Arrest 26% Stock Slide

05.06.2026 - 18:48:57 | boerse-global.de

Norwegian hydrogen firm Nel ASA sees shares drop nearly 9% in a day, erasing 2025 gains, as short-term market sentiment diverges from long-term industrial ambitions.

Nel ASA Stock Plunges 26% Despite €135M EU Grant for Hydrogen Expansion
Nel - Nel ASA's €135M EU Grant and New Electrolyzer Platform Fail to Arrest 26% Stock Slide 05.06.2026 - Bild: über boerse-global.de

The disconnect between long-term industrial ambition and short-term market sentiment is playing out in stark relief at Nel ASA. Even as the Norwegian hydrogen specialist secures a €135 million grant from the European Union’s Innovation Fund to ramp up production at Herøya and rolls out a next-generation pressurized alkaline platform, its shares have shed nearly a quarter of their value in a single week.

The sell-off accelerated on Friday, with the stock closing at €0.27 — a drop of close to 9% on the day. That puts the equity 26% below the 52-week high of €0.37 reached just a fortnight earlier on 25 May. Notably, the slide has occurred without any fresh company-specific news, a stark reminder of how quickly sentiment can shift in the volatile hydrogen sector.

Before the latest leg lower, the stock had still been up more than 54% for the year. That year-to-date gain has now been trimmed to roughly 40%, a level that masks sharply diverging fortunes for investors: those who bought early remain comfortably in profit, while anyone who piled in during May is nursing losses. The annualized 30-day volatility is running above 100% — a clear red flag for extreme swings in either direction.

Should investors sell immediately? Or is it worth buying Nel ASA?

Nel’s management has been busy on the strategic front. On 6 May it unveiled its new pressurized alkaline electrolyzer platform, the culmination of over eight years of development and prototype testing at Herøya. The system aims to simplify hydrogen projects and cut costs: the target is under $1,450 per kilowatt for a 25-megawatt installation. That technology push is now backed by a three-digit million euro boost from Brussels — up to €135 million from the EU’s Innovation Fund — covering a large chunk of the eligible industrialization costs. The roadmap calls for an initial capacity of one gigawatt per year at Herøya, with potential expansion to four gigawatts depending on market demand.

Financials, however, offer little comfort for those looking for immediate returns. In the first quarter, Nel posted revenue of NOK 148 million, a 5% decline from the year-ago period. EBITDA came in at minus NOK 100 million, an improvement from the NOK 115 million loss in the prior-year quarter. On a per-share basis, the net loss was NOK 0.08. The company holds roughly NOK 1.4 billion in cash, providing a decent runway — but it remains firmly in a transition phase, with profits nowhere in sight.

Technically, the stock is still just above its 50-day moving average of €0.26, but that cushion has become precarious. The relative strength index sits at 42.8, signaling that while the stock is not yet oversold, buying momentum has clearly cooled. If the 50-day line gives way, the next major anchor is the 200-day average, which still lies well below — underlining that the medium-term uptrend is intact but vulnerable.

All eyes now turn to 15 July, when Nel’s board will release preliminary second-quarter figures. After years of product promises and a factory expansion underwritten by the EU, investors are demanding the one thing that has been conspicuously absent: concrete order conversions. The coming weeks will show whether the new platform and Herøya scale-up can finally translate into commercial traction — or whether the stock’s recent retreat is just the beginning of a deeper correction.

Ad

Nel ASA Stock: New Analysis - 5 June

Fresh Nel ASA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Nel ASA analysis...

en | NO0010081235 | NEL | boerse | 69488947 |